5 Best Pharma Dividend Stocks To Buy in 2024

2. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 98

Merck & Co., Inc. (NYSE:MRK) is an American pharmaceutical company that is dedicated to improving the health and well-being of people and animals worldwide by delivering innovative and effective medical solutions. The company offers a quarterly dividend of $0.77 per share and has a dividend yield of 2.49%, as of March 4. It has raised its dividends for 13 years in a row, which makes MRK one of the best dividend stocks in the pharma sector.

Merck & Co., Inc. (NYSE:MRK) remained popular among elite funds in Q4 2023 as the company ended the quarter with 98 hedge fund positions, up from 85 in the preceding quarter, according to our database. The stakes held by these hedge funds are worth over $7.16 billion in total.

Follow Merck & Co. Inc. (NYSE:MRK)